Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03977116
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03977116
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT03977116. Randomized; single masking; primary purpose prevention. Start 2017-01-01 (actual); primary completion 2019-01-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients
- Condition
- Diabetes Mellitus
- Condition
- Heart Failure
- Condition
- Ventricular Arrythmia
- Intervention (Drug)
- SLGT2
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Campania Luigi Vanvitelli
Record details
- Record id
cardio:ct-nct03977116- Content hash
0880fd4c984e7f9e907352b49f587322ec2622af1b55765c2a81f475ac8e3846